AI Medical Service Inc. announces FDA Breakthrough Device Designation for endoscopic AI system
- Monday, November 11, 2019, 7:19
- Business
- Add a comment
TOKYO, Nov. 11, 2019 /PRNewswire/ — AI Medical Service Inc., one of the world’s first real-time endoscopic artificial intelligence (AI) developers, today announced the Company has secured Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its AI programs…
About the Author
adminasapcorp has written 41779 stories on this site.